JANX
Janux Therapeutics Inc.
$26.35
-$0.17(-0.62%)
67
Overall
60
Value
80
Tech
63
Quality
Market Cap
$1.59B
Volume
849.69K
52W Range
$21.73 - $71.71
Target Price
$81.20
Key Metrics Overview
| Market Cap | $1.59B | P/E Ratio | N/A |
| 52W High | $71.71 | 52W Low | $21.73 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 2.7% | 52W Position | 9.2% |
| Overall Score | 67 | Value Score | 60 |
| Quality Score | 63 | Technical Score | 80 |
Growth Analysis
| EPS Current Est | $-2.37 | EPS Next Est | $-3.24 |
| EPS Growth Est | N/A | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | JANX | $26.35 | -0.6% | 849.69K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |